Intellia Therapeutics, Inc. (NTLA) vs Teladoc Health, Inc. (TDOC)

A side-by-side comparison of Intellia Therapeutics, Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NTLA vs TDOC

growth of $100 · dividends reinvested · last 10y
NTLA -28.8% (-3.3%/yr)TDOC -68.2% (-10.8%/yr)NTLA compounded faster over this window
05001k2kStart $10020182020202220242026$71$32
NTLA TDOC

NTLA vs TDOC: by the numbers

  • •NTLA is the larger company ($1.71B vs $1.00B market cap).
  • •Both run net losses; TDOC's is the smaller (-7.13% vs -672.16% net margin).
  • •TDOC grew revenue faster over the past five years (8.85% vs 7.31% CAGR).

Metrics side by side

Valuation

MetricNTLATDOC
P/S ratio28.790.40
P/B ratio2.350.77
EV / EBITDAN/A12.45
FCF yieldN/A22.40%

Profitability

MetricNTLATDOC
Gross margin76.47%73.53%
Operating margin-651.67%-6.98%
Net margin-672.16%-7.13%
ROE-54.96%-13.54%
ROIC-54.45%-7.32%

Growth (annualized)

MetricNTLATDOC
Revenue CAGR (5Y)7.31%8.85%
Total return CAGR (5Y)-38.17%-46.28%

Frequently asked

Which has grown faster, NTLA or TDOC?
Over the past five years, TDOC grew revenue faster — NTLA at a 7.31% CAGR versus TDOC at 8.85%.
How have NTLA and TDOC total returns compared?
Over the past 10 years, NTLA delivered -3.34% and TDOC delivered -11.06% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.